Pharmaceutical Intermediate - Fine Chemical

Faithful And Valuable Partner

> Click To See More

Profession Builds
Long Lasting Cooperation

> Click To See More

Bridge Connecting You
To China

> Click To See More

OUR SPECIALITIES

We have been specialized in exporting and importing pharmaceutical intermediates and chemical products as well as API for more than 10+ years, covering all over world, such as USA, Canada, England, French and so on.

R & D

Fully equipped research facility to support Sandoo’s internal supply chain and to offer custom R&D services.
FACILITIES

We are supported by all kinds, including FDA approved, GMP as well as GMP like sites.
COMPLIANCE

Our facilities are designed to comply with ICH 2022 working draft guidelines for quality standards.

Find Your Product

Enter the CAS No.

Product Name
Product Keyword
Product Model
Product Summary
Product Description
Multi Field Search

MORE APPLICATIONS

OUR FACILITIES

We have a creative and outstanding team.

OUR CORE STRENGTHS

To be harder, faster, stronger and better, to win invaluable trust from every customer.

AUTOMATED MANUFACTURING

GAMP 5 compliant, Distributed Control System (DCS) enabled manufacturing line that provides excellent control over operating parameters to deliver consistent quality output batch over batch.

COMPLETELY BACKWARD INTEGRATED

Our manufacturing facilities are both independent as well as integrable with each other; starting from fine chemicals to advanced pharmaceutical intermediates to APIs.

RICH LEARNING ENVIRONMENT

Our employees enjoy a rich learning-oriented atmosphere, enabling them to reach global standards and become a benchmark for knowledge.

QUALITY & INTEGRITY

Our approach to quality and Integrity is transparancy. Our facilities and systems are designed based on QbD principles.

What is the difference between API and FDF in pharma？

In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations.

2020-08-19

→

Intermediates of Eribulin Mesylate

Eribulin is a chemotherapy drug. Its full name is eribulin mesylate. Eribulin is a microtubule inhibitor indicated for the treatment of patients with metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic disease.

2020-12-28

→

Prostate Cancer and Darolutamide

Darolutamide was approved by FDA on Jul 30, 2019, and approved by the EMA on March 27, 2020, the trade name is Nubeqa. The drug was research by Orinon, the on Jun 2014, Bayer got the global development and commercial right in the world. Its molecular conformation is different from Enzalutamide and Apalutamide, and its unique chemical structure enables this drug to inhibit the growth of cancer cells by blocking the function of androgen receptors by blocking nuclear ectopic.

2020-12-23

Write To Us

REQUEST A QUOTE

● Latest products in the market.

● Best wholesale price.

REQUEST A QUOTE

● Detailed product features.

● Customized options you can have.

R & D

FACILITIES

COMPLIANCE

What is the difference between API and FDF in pharma？

Intermediates of Eribulin Mesylate

Prostate Cancer and Darolutamide

REQUEST A QUOTE

REQUEST A QUOTE

REQUEST A QUOTE

QUICK LINKS

CONTACT US

SEARCH PRODUCT